NO972612D0 - Pyridazoner som endotelinreseptorantagonister - Google Patents
Pyridazoner som endotelinreseptorantagonisterInfo
- Publication number
- NO972612D0 NO972612D0 NO972612A NO972612A NO972612D0 NO 972612 D0 NO972612 D0 NO 972612D0 NO 972612 A NO972612 A NO 972612A NO 972612 A NO972612 A NO 972612A NO 972612 D0 NO972612 D0 NO 972612D0
- Authority
- NO
- Norway
- Prior art keywords
- pyridazones
- receptor antagonists
- endothelin receptor
- endothelin
- antagonists
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/14—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19537548A DE19537548A1 (de) | 1995-10-09 | 1995-10-09 | Endothelin-Rezeptor-Antagonisten |
| PCT/EP1996/004111 WO1997013758A1 (de) | 1995-10-09 | 1996-09-19 | Pyridazinone als endothelin-rezeptor-antagonisten |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO972612D0 true NO972612D0 (no) | 1997-06-06 |
| NO972612L NO972612L (no) | 1997-08-08 |
Family
ID=7774384
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO972612A NO972612L (no) | 1995-10-09 | 1997-06-06 | Pyridazoner som endotelinreseptorantagonister |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5883090A (no) |
| EP (1) | EP0796250A1 (no) |
| JP (1) | JPH10511118A (no) |
| CN (1) | CN1168137A (no) |
| AR (1) | AR004689A1 (no) |
| AU (1) | AU7211996A (no) |
| BR (1) | BR9606668A (no) |
| CA (1) | CA2207243A1 (no) |
| CZ (1) | CZ176897A3 (no) |
| DE (1) | DE19537548A1 (no) |
| HU (1) | HUP9801879A3 (no) |
| NO (1) | NO972612L (no) |
| PL (1) | PL320638A1 (no) |
| SK (1) | SK73597A3 (no) |
| WO (1) | WO1997013758A1 (no) |
| ZA (1) | ZA968483B (no) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6187920B1 (en) | 1998-03-26 | 2001-02-13 | Sumitomo Chemical Co., Ltd. | Pyridazinone derivatives |
| GB0023074D0 (en) * | 2000-09-20 | 2000-11-01 | Pfizer Ltd | Pyridazines |
| US6670362B2 (en) * | 2000-09-20 | 2003-12-30 | Pfizer Inc. | Pyridazine endothelin antagonists |
| US6996060B1 (en) | 2001-03-20 | 2006-02-07 | Arraycomm, Inc. | Closing a communications stream between terminals of a communications system |
| US7339906B1 (en) * | 2001-03-20 | 2008-03-04 | Arraycomm, Llc | Opening a communications stream between a user terminal and a base station |
| DE10155076A1 (de) * | 2001-11-09 | 2003-05-22 | Merck Patent Gmbh | Verwendung von Endothelin-Rezeptor-Antagonisten zur Behandlung von Tumorerkrankungen |
| BRPI0514544A (pt) | 2004-08-23 | 2008-06-17 | Wyeth Corp | ácidos de oxazol-naftila como moduladores de inibidor tipo-1 de ativador de plasminogênio (pai-1) |
| CA2577782A1 (en) * | 2004-08-23 | 2006-03-02 | Wyeth | Pyrrolo-naphthyl acids as pai-1 inhibitors |
| KR20070045353A (ko) | 2004-08-23 | 2007-05-02 | 와이어쓰 | 플라스미노겐 활성화제 억제제-1의 억제제로서티아졸로-나프틸 산 |
| CN109867613B (zh) * | 2017-12-01 | 2021-08-17 | 中国科学院大连化学物理研究所 | 一种多取代苯甲酸及其合成方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2832780A (en) * | 1955-09-14 | 1958-04-29 | Warner Lambert Pharmaceutical | Hydrazides of pyridazonyl-substituted alkanoic acids |
| JPS57501328A (no) * | 1980-08-07 | 1982-07-29 | ||
| ES2164054T3 (es) * | 1991-11-05 | 2002-02-16 | Smithkline Beecham Corp | Antagonistas de receptores de endotelina. |
| ZA939516B (en) * | 1992-12-22 | 1994-06-06 | Smithkline Beecham Corp | Endothelin receptor antagonists |
| DK0617001T3 (da) * | 1993-03-19 | 2000-04-17 | Merck & Co Inc | Phenoxyphenyleddikesyrederivater |
| DE4339868A1 (de) * | 1993-11-23 | 1995-05-24 | Merck Patent Gmbh | Imidazopyridazine |
| RU2155188C2 (ru) * | 1994-03-10 | 2000-08-27 | Фудзисава Фармасьютикал Со., Лтд. | Производные нафталина, фармацевтическая композиция |
-
1995
- 1995-10-09 DE DE19537548A patent/DE19537548A1/de not_active Withdrawn
-
1996
- 1996-09-10 AR ARP960104655A patent/AR004689A1/es unknown
- 1996-09-19 US US08/849,344 patent/US5883090A/en not_active Expired - Fee Related
- 1996-09-19 BR BR9606668A patent/BR9606668A/pt not_active Application Discontinuation
- 1996-09-19 CA CA002207243A patent/CA2207243A1/en not_active Abandoned
- 1996-09-19 EP EP96933341A patent/EP0796250A1/de not_active Withdrawn
- 1996-09-19 JP JP9514665A patent/JPH10511118A/ja active Pending
- 1996-09-19 CZ CZ971768A patent/CZ176897A3/cs unknown
- 1996-09-19 SK SK735-97A patent/SK73597A3/sk unknown
- 1996-09-19 CN CN96191388A patent/CN1168137A/zh active Pending
- 1996-09-19 HU HU9801879A patent/HUP9801879A3/hu unknown
- 1996-09-19 AU AU72119/96A patent/AU7211996A/en not_active Abandoned
- 1996-09-19 PL PL96320638A patent/PL320638A1/xx unknown
- 1996-09-19 WO PCT/EP1996/004111 patent/WO1997013758A1/de not_active Application Discontinuation
- 1996-10-08 ZA ZA968483A patent/ZA968483B/xx unknown
-
1997
- 1997-06-06 NO NO972612A patent/NO972612L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2207243A1 (en) | 1997-04-17 |
| MX9704262A (es) | 1997-09-30 |
| ZA968483B (en) | 1997-05-20 |
| AU7211996A (en) | 1997-04-30 |
| SK73597A3 (en) | 1998-05-06 |
| US5883090A (en) | 1999-03-16 |
| HUP9801879A3 (en) | 1999-07-28 |
| AR004689A1 (es) | 1999-03-10 |
| PL320638A1 (en) | 1997-10-13 |
| EP0796250A1 (de) | 1997-09-24 |
| NO972612L (no) | 1997-08-08 |
| BR9606668A (pt) | 1997-09-30 |
| CN1168137A (zh) | 1997-12-17 |
| HUP9801879A2 (hu) | 1999-06-28 |
| JPH10511118A (ja) | 1998-10-27 |
| DE19537548A1 (de) | 1997-04-10 |
| CZ176897A3 (en) | 1997-10-15 |
| WO1997013758A1 (de) | 1997-04-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI960953A (fi) | Endoteliinireseptoriantagonisteja | |
| FI961804A0 (fi) | Endoteliinireseptoriantagonistit | |
| NO972016D0 (no) | Indolyl-Y-reseptorantagonister | |
| DE69812096D1 (de) | Neuropeptid y rezeptorantagonisten | |
| DE69734833D1 (de) | Vitronektin rezeptor antagonisten | |
| NO985225L (no) | Indolderivater nyttige som endotelinreseptorantagonister | |
| NO951613D0 (no) | Ikke-peptidyl tachykinin reseptorantagonister | |
| DE69327720D1 (de) | Endothelin rezeptor antagonisten | |
| FI960516A0 (fi) | Substituoituja bifenyylisulfonamidiendoteliiniantagonisteja | |
| ATE213156T1 (de) | Endothelin-rezeptor-antagonisten | |
| ZA969775B (en) | Endothelin receptor antagonists. | |
| ID24726A (id) | Antagonis-antagonis reseptor trombin | |
| NO20000542L (no) | Endothelin-antagonister | |
| ID24162A (id) | Antagonis-antagonis reseptor vitronektin | |
| DK0906294T3 (da) | Benzoxazinon-dopamin D4-receptor-antagonister | |
| BR9507220A (pt) | Antagonistas de receptores de endotelina | |
| NO972612D0 (no) | Pyridazoner som endotelinreseptorantagonister | |
| DE69636597D1 (de) | Endothelin rezeptor antagonisten | |
| HU9602054D0 (en) | Endothelin receptor antagonists | |
| EP0854721A4 (en) | ENDOTHELIN RECEPTOR ANTAGONISTS | |
| ZA966552B (en) | Endothelin receptor antagonists. | |
| BR9603432A (pt) | Antagonistas de receptores de endotelina | |
| EP0841926A4 (en) | ENDOTHELIN RECEPTOR ANTAGONISTS | |
| EP0841916A4 (en) | ENDOTHELINE RECEPTOR ANTAGONISTS | |
| EP0868180A4 (en) | ENDOTHELINM RECEPTOR ANTOGONISTS |